The prediction was that by blocking RIOK1, we could promote the cell susceptibility required for apoptosis and mark RIOK1 as a potential anticancer therapy, representing a new strategy for targeting CRC MSI-High p53-Mut cell lines. Here, RIOK1 is linked to colorectal carcinoma.